共 35 条
- [1] Litovitz, Bailey, Schmitz, Et al., 1990 Annual Report of the American Association of Poison Control Centers National Data Collection System, Am J Emerg Med, 9, pp. 461-509, (1991)
- [2] Hirotoshi, Eichelbaum, Clinical pharmacokinetics of verapamil, nifedipine and diltiazem, Clin Phamacokinet, 11, pp. 425-449, (1980)
- [3] Schlepper, Thorman, Schwarz, The phamacodynamics of orally taken verapamil and verapamil retard as judged by their negative dromotropic effects, Arzneim Forsch, 25, pp. 1452-1455, (1975)
- [4] Ellenhorn, Barceloux, Medical Toxicology Diagnosis and Treatment of Human Poisoning, pp. 195-200, (1988)
- [5] Mitchell, Schroeder, Mason, Comparative clinical electrophysiologic effects of diltiazem, verapamil and nifedipine: A review, Am J Cardiol, 49, pp. 629-635, (1982)
- [6] Gelbke, Schlicht, Schmidt, Fatal poisoning with verapamil, Arch Toxicol, 37, pp. 89-94, (1977)
- [7] Antman, Stone, Muller, Et al., Calcium blocking agents in the treatment of cardiovascular disorders: Part 1. Basic electrophysiologic effects, Ann Intern Med, 93, pp. 875-885, (1980)
- [8] Stone, Antman, Muller, Et al., Calcium blocking agents in the treatment of cardiovascular disorders: Part II. Hemodynamic effects and applications, Ann Intern Med, 93, pp. 886-904, (1980)
- [9] Lewin, Howland, Calcium channel blockers, Goldfrank's Toxicological Emergencies, pp. 372-374, (1990)
- [10] Neugebauer, Comparative cardiovascular actions of verapamil and its major metabolites in the anaesthetized dog, Cardiovasc Res, 12, pp. 247-254, (1978)